Cargando…
FFAR4 regulates cardiac oxylipin balance to promote inflammation resolution in HFpEF secondary to metabolic syndrome
Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome, but a predominant subset of HFpEF patients has metabolic syndrome (MetS). Mechanistically, systemic, nonresolving inflammation associated with MetS might drive HFpEF remodeling. Free fatty acid receptor 4 (Ffar4)...
Autores principales: | Zhang, Naixin, Harsch, Brian, Zhang, Michael J., Gyberg, Dylan J., Stevens, Jackie A., Wagner, Brandon M., Mendelson, Jenna, Patterson, Michael T., Orchard, Devin A., Healy, Chastity L., Williams, Jesse W., Townsend, DeWayne, Shearer, Gregory C., Murphy, Katherine A., O'Connell, Timothy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209340/ https://www.ncbi.nlm.nih.gov/pubmed/37075982 http://dx.doi.org/10.1016/j.jlr.2023.100374 |
Ejemplares similares
-
Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022) -
Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022) -
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
por: Grossekettler, Leonie, et al.
Publicado: (2020) -
Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021) -
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
por: Borlaug, Barry A., et al.
Publicado: (2023)